The Emirates Drug Establishment (EDE) has carried out more than 568 inspections of medical warehouses across the country since the beginning of the year, including 86 inspections in March, as part of efforts to secure medicine stockpile.
The inspection findings help monitor medicine movement and support decision-making, while ensuring compliance with storage, transport and regulatory standards, while promoting best practices.
Dr. Fatima Al Kaabi, Director-General of the EDE, said drug security remains a national priority, with a focus on ensuring the availability, safety and quality of medicines while supporting the development of the domestic pharmaceutical sector.
Faris Almaazmi, Director of Inspection and Control Department at the EDE, said inspection teams operate under regular oversight programmes and risk-based inspection methodologies, while also monitoring medicine movements within warehouses and verifying the accuracy of documentation and traceability procedures to promote compliance among pharmaceutical establishments.
Pharmaceutical market data indicate stable and reassuring levels of medicine availability, underpinned by a secure and sufficient strategic stockpile covering local demand for extended periods, and supported by advanced regulatory capabilities that enhance the efficiency and resilience of the pharmaceutical ecosystem.
EDE said it will continue to expand the use of digital tools and data analytics to strengthen oversight, improve efficiency and support market stability and reinforce drug security in the UAE.

UAE, Saudi Arabia and allies condemn Israeli minister over flotilla detainees
UAE President joins call with Trump, regional leaders to discuss Iran peace deal
UAE, UN discuss expediting access to clean water ahead of world conference
UAE delegation concludes participation in GLOBSEC Forum 2026 in Prague
